VRDN Financing Cash Flow
Viridian Therapeutics Ors Inc · Financing Cash Flow
VRDN Financing Cash Flow
Latest reported$748.24Mperiod ending
VRDN TTM Cash from Financing ($1.26M → $748.24M)
TTM financing cash flow
High-resolution chart · PNG
VRDN financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 748,244,000 | |
| 423,887,000 | |
| 426,742,000 | |
| 56,357,000 | |
| 290,523,000 | |
| 289,867,000 | |
| 457,737,000 | |
| 621,154,000 | |
| 391,588,000 | |
| 394,548,000 | |
| 225,670,000 | |
| 52,743,000 | |
| 328,220,000 | |
| 329,710,000 | |
| 322,244,000 | |
| 296,400,000 | |
| 122,260,000 | |
| 124,754,000 | |
| 125,275,000 | |
| 202,788,000 | |
| 90,639,000 | |
| 84,855,000 | |
| 101,311,000 | |
| 24,423,000 | |
| 18,874,000 | |
| 17,567,000 | |
| 70,000 | |
| -735,000 | |
| 1,283,000 | |
| 4,020,000 | |
| 41,916,000 | |
| 53,839,000 | |
| 54,921,000 | |
| 51,468,000 | |
| 52,470,000 | |
| 40,424,000 | |
| 38,202,000 | |
| 38,906,000 | |
| -257,000 | |
| -94,000 | |
| 3,916,000 | |
| 3,357,000 | |
| 12,706,000 | |
| 12,665,124 | |
| 8,212,513 | |
| 16,888,412 | |
| 7,397,000 | |
| 7,751,158 | |
| 8,497,310 | |
| 624,671 | |
| 1,258,922 |